STAT+: Employers drop coverage for weight loss drugs as pharma’s direct-to-consumer programs grow
When HCA Healthcare, one of the largest hospital systems in the U.S., recently told employees it would stop covering blockbuster obesity drugs Zepbound and Wegovy next year, it pointed them to an